Table 2.
Discontinuation vs continuation by age, gender, ethnicity, and race category
| Number of observations stratified by whether the high-risk medication use was discontinued (n = 802,475)a | |||
|---|---|---|---|
| Continuation | Discontinuation | ||
| 621,363 (77.4%) | 181,112 (22.6%) | ||
| Age | 65 to 74 years | 350,567 (75.4%) | 114,631 (24.6%) |
| ≥75 years | 270,796 (80.3%) | 66,481 (19.7%) | |
| Gender | Female | 365,659 (76.5%) | 112,096 (23.5%) |
| Male | 255,704 (78.8%) | 69,016 (21.3%) | |
| Race | Asian | 10,759 (76.7%) | 3,274 (23.3%) |
| Black | 33,003 (77.1%) | 9,833 (22.9%) | |
| No database-recorded race | 392,595 (77.4%) | 114,622 (22.6%) | |
| White | 185,006 (77.6%) | 53,383 (22.4%) | |
| Ethnicity | Hispanic | 34,379 (76.5%) | 10,570 (23.5%) |
| Non-Hispanic | 169,286 (77.6%) | 48,807 (22.4%) | |
| No database-recorded ethnicity | 417,698 (77.4%) | 121,735 (22.6%) | |
a802,475 observations from 729,705 unique individuals. Among these unique individuals, 166,613 (22.8%) discontinued at least one high-risk medication.